# AbbVie Inc. (ABBV) FY2026 Q1 Balance Sheet

- Company: AbbVie Inc. (ABBV)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-08, accession number 0001551152-26-000017
- Page: https://plicit.ai/financials/abbv/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/abbv-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 136,463,000,000 US dollars
- **Current assets**: 33,529,000,000 US dollars
- **Non-current assets**: 102,934,000,000 US dollars
- **Liabilities (calculated)**: 143,075,000,000 US dollars
- **Current liabilities**: 42,100,000,000 US dollars
- **Non-current liabilities**: 100,975,000,000 US dollars
- **Equity**: negative 6,612,000,000 US dollars
- **Noncontrolling interest**: 44,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 12,479,000,000 US dollars
- **Cash and equivalents**: 9,391,000,000 US dollars
- **Prepaid expenses and other**: 6,610,000,000 US dollars
- **Inventories**: 5,049,000,000 US dollars
- **Intangible assets, net**: 50,873,000,000 US dollars
- **Goodwill**: 35,570,000,000 US dollars
- **Other assets**: 10,536,000,000 US dollars
- **Property and equipment, net**: 5,687,000,000 US dollars
- **Investments**: 268,000,000 US dollars
- **Accounts payable and accrued liabilities**: 33,774,000,000 US dollars
- **Current portion of long-term debt**: 8,326,000,000 US dollars
- **Short-term borrowings**: 0 US dollars
- **Long-term debt**: 64,532,000,000 US dollars
- **Other long-term liabilities**: 34,111,000,000 US dollars
- **Deferred income taxes**: 2,332,000,000 US dollars
- **Additional paid-in capital**: 22,962,000,000 US dollars
- **Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,843,809,386 shares issued as of March 31, 2026 and 1,838,678,628 as of December 31, 2025**: 18,000,000 US dollars
- **Noncontrolling interest**: 44,000,000 US dollars
- **Accumulated deficit**: negative 17,872,000,000 US dollars
- **Common stock held in treasury, at cost, 77,077,199 shares as of March 31, 2026 and 70,802,593 as of December 31, 2025**: negative 10,611,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,153,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.